1990 …2024

Research output per year

If you made any changes in Pure these will be visible here soon.

Projects

Filter
Active

A Randomized, Multi-center, Phase 3 Study of Nivolumab in Combination with Ipilimumab Compared to Sorafenib or Lenvatinib as First-Line Treatment in Participants with Advanced Hepatocellular Carcinoma.

Roberts, S., Lewis, P., George, J., Zekry, A., O'Beirne, J., Tse, E., McLachlan, S., Eastgate, M., Ananda, S. S. & Davison, S.

24/09/1930/09/23

Project: Research